Download PDF

 

Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2024 ended June 30, 2024.

 

Q3 Fiscal Year 2024 

  • Good equipment book-to-bill ratio of 1.07 further increases already high order backlog 
  • Comparable revenue growth of 4.3% against a very strong prior-year quarter (10.1% excluding rapid COVID-19 antigen tests) and despite continued order delays in China 
  • Imaging comparable revenue growth of 3.8% against sharp growth in the prior-year quarter; adjusted EBIT margin of 20.0% 
  • Diagnostics comparable revenue growth of 2.1%; adjusted EBIT margin of 7.4% clearly above the prior-year quarter 
  • Varian comparable revenue growth of 9.6%; adjusted EBIT margin of 16.6% shows clear improvement over prior-year quarter 
  • Advanced Therapies comparable revenue growth of 0.4% against significant growth in the prior-year quarter; adjusted EBIT margin of 13.9% 
  • Overall adjusted EBIT margin of 15.2% 
  • Adjusted basic earnings per share of €0.52

 

Outlook for Fiscal Year 2024 

We confirm our expectation of comparable revenue growth of between 4.5% and 6.5% (between 5.0% and 7.0% excluding revenue from rapid COVID-19 antigen tests) and adjusted basic earnings per share of between €2.10 and €2.30. 

 

Bernd Montag, CEO of Siemens Healthineers AG: 

We made good progress again in the third quarter, despite ongoing order delays in China. Varian and Diagnostics especially contributed to the strong operating performance. We confirm our outlook for the financial year.

 

Source & Image Credit: Siemens Healthineers

 



Siemens Healthineers, revenue growth, EBIT margin, fiscal year 2024, Q3 2024 results

Latest Articles

  • Most Regrettable Business Decisions

      Regrettable healthcare management decisions—errors, missed opportunities, and resource allocation pitfalls—can be profoundly costly and impactful. The ripple effects of such missteps can strain operational efficiency, compromise patient care, and erode the essential trust that underpins the re

    READ MORE
  • Why Do So Many Healthcare Innovation Initiatives Fail?

      Successful healthcare innovation requires more than technical and clinical expertise; it demands a deep understanding of the ecosystem, including regulatory requirements, reimbursement systems, and organisational dynamics. Embracing a holistic approach, fostering continuous feedback, and enga

    READ MORE
  • How Cultural Differences Can Make or Break Mergers and Acquisitions

      Organisational culture has a pivotal impact on M&A success. Neglecting cultural differences can lead to reduced productivity, operational hurdles, and strategic misalignments. Proactive strategies like cultural assessments and effective communication foster integration and enhance overal

    READ MORE
Siemens Healthineers Q3 results, fiscal year 2024, Siemens imaging growth, diagnostics performance, Varian revenue, Siemens Healthineers outlook Siemens Healthineers Q3 FY 2024 results show solid growth in imaging, diagnostics, and Varian, with a strong order backlog and confirmed fiscal outlook.